NCT00177710View on ClinicalTrials.gov

Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

December 31, 2007

Conditions

Lung TransplantationFungal Infections

Interventions

DRUG

Amphotericin B

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors

collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00177710 - Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study | Biotech Hunter | Biotech Hunter